Prab at 01:53, 26 September 2023

2023-09-26T01:53:25Z

New page

[[File:Iocarmic acid.png|Iocarmic acid|thumb]]
'''Iocarmic acid''' is a specialized organoiodine compound that has garnered attention in the medical community due to its pivotal role as a [[contrast medium]] in diagnostic radiographic procedures.
=== Chemical and Physical Properties ===
Being an iodinated molecule, iocarmic acid's primary asset lies in its ability to absorb X-rays with greater efficiency than the surrounding human tissues. This property stems from the high iodine content within the molecule, making it particularly effective at enhancing the contrast in radiographic images<ref>Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1991). Intravascular contrast material administration in current radiologic practice: a comprehensive overview. ''Radiology'', 180(1), 13-21.</ref>.
=== Clinical Utility ===
Iocarmic acid is employed in a diverse range of imaging studies to improve the visualization of structures and vessels, including:
* [[Computed Tomography (CT)]] scans
* [[Angiography]]
* [[Hysterosalpingography]]
By emphasizing the disparity between the organ or vessel of interest and its adjacent structures, iocarmic acid significantly augments the diagnostic accuracy of these procedures<ref>Manzke, R., Meyer, B. C., Frenzel, T., & Wedegärtner, U. (2019). Applications of ionic and nonionic contrast media in radiology. ''Rofo'', 191(1), 24-30.</ref>.
=== Pharmacokinetics ===
Upon intravascular administration, iocarmic acid disseminates into the extracellular fluid compartment. Its removal from the system is predominantly orchestrated by renal excretion. As a result, the rate of its clearance closely mirrors renal function, underscoring the need for dosage adjustments in patients with renal insufficiencies<ref>Barrett, B. J., & Parfrey, P. S. (2005). Clinical practice. Preventing nephropathy induced by contrast medium. ''The New England journal of medicine'', 352(3), 239-246.</ref>.
=== Safety Profile and Potential Adverse Reactions ===
While iocarmic acid generally manifests a favorable safety profile for a majority of patients, vigilant monitoring for potential adverse effects remains paramount. Common reactions include:
* Warmth or flushing sensation at the site of injection
* Transient nausea or dizziness
However, rare but severe reactions might include:
* [[Anaphylactic shock]]
* Hypotensive episodes
* Respiratory compromise
Immediate clinical intervention is warranted in the face of such adverse reactions<ref>Pannu, N., & Wiebe, N. (2008). Prophylaxis strategies for contrast-induced nephropathy. ''JAMA'', 299(23), 2773-2783.</ref>.
=== Conclusion ===
The advent of iocarmic acid has greatly advanced the field of radiology by offering a reliable and effective contrast medium for various diagnostic studies. Its ability to sharply delineate anatomical structures has proven invaluable for both clinicians and researchers alike.
{{pharmacology-stub}}
{{Contrast media}}
== References ==
* Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1991). Intravascular contrast material administration in current radiologic practice: a comprehensive overview. ''Radiology'', 180(1), 13-21.
* Manzke, R., Meyer, B. C., Frenzel, T., & Wedegärtner, U. (2019). Applications of ionic and nonionic contrast media in radiology. ''Rofo'', 191(1), 24-30.
* Barrett, B. J., & Parfrey, P. S. (2005). Clinical practice. Preventing nephropathy induced by contrast medium. ''The New England journal of medicine'', 352(3), 239-246.
* Pannu, N., & Wiebe, N. (2008). Prophylaxis strategies for contrast-induced nephropathy. ''JAMA'', 299(23), 2773-2783.
[[Category:Radiocontrast agents]]
[[Category:Organoiodides]]
[[Category:Benzoic acids]]
[[Category:Benzamides]]
[[Category:Anilides]]

Iocarmic acid - Revision history

Prab at 01:53, 26 September 2023